We are pleased to announce that our practice has acquired a new, FDA-approved technology that uses ultrasound combined with sophisticated computer analysis to detect and monitor the health of arterial blood vessels. The procedure is called ArterioVision ™. It measures Carotid Intima Media Thickness (cIMT), the thickness of the part of the artery wall which correlates with heart disease. The thicker the carotid artery’s inner two layers (intima-media), the greater is one’s risk for heart attack or stroke.
The ultrasound procedure is comfortable, safe, and highly accurate. It uses the same kind of ultrasound that is used to take pictures of babies in the womb. The exam provides, among other things, a comparison of your current age to your arterial age (i.e. the age of your arteries). Based on your results, we can institute therapies and recommend lifestyle modifications to help arrest or even reverse heart disease and stroke. Since the cIMT procedure is repeatably reliable, it can be used over time to measure treatment effectiveness. With proper treatment it is entirely possible for your cIMT to decrease which indicates a decrease in your risk for heart attack and stroke.
The ArterioVision test will also be used in our office to eliminate unnecessary treatment in those patients who may have certain abnormalities but very healthy arteries!
The science behind this procedure was developed at the California Institute of Technology (Caltech)/Jet Propulsion laboratory (JPL) and USC’s Keck School of Medicine. It has been applied in thousands of patients world wide to guide treatment. It is highly validated and gives a precise quantitative measurement unavailable through standard treadmill testing (“stress test”).
Get In touch
Leave us a message